PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY was reported 13 times

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 3 0.0018
1 BRENTUXIMAB VEDOTIN 2 0.0002
2 VINORELBINE 1 0.0001
3 BENDAMUSTINE HCL 1 0.0001
4 DOXORUBICIN HYDROCHLORIDE 1 0.0000
5 PREDNISOLONE ORAL SOLUTION 4 0.0000
6 GEMCITABINE HYDROCHLORIDE 1 0.0000
7 CYCLOPHOSPHAMIDE FOR INJECTION 3 0.0000
8 CYCLOPHOSPHAMIDE 3 0.0000
9 ANTI-ITCH CREAM 1 0.0000
10 HYDROCORTISONE LOTION 1 0.0000
11 HYDROCORTISONE CREAM 1% 1 0.0000
12 HYDROCORTISONE ACETATE 1 0.0000
13 HYDROCORTISONE 1 0.0000
14 DOXORUBICIN 1 0.0000
15 TACROLIMUS OINTMENT 0.1% 1 0.0000
16 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
17 TACROLIMUS 1 0.0000
18 LENALIDOMIDE 2 0.0000
19 RITUXIMAB 1 0.0000
20 METHOTREXATE SODIUM 1 0.0000
21 PREDNISONE 1 0.0000